UZH-Logo

Maintenance Infos

Efficacy and safety of Apo866 in patients with refractory or relapsed cutaneous t-cell lymphoma: a phase 2 clinical trial


Goldinger, Simone M; Gobbi Bischof, Sharon; Fink-Puches, Regina; Klemke, Claus-Detlev; Dréno, Brigitte; Bagot, Martine; Dummer, Reinhard (2016). Efficacy and safety of Apo866 in patients with refractory or relapsed cutaneous t-cell lymphoma: a phase 2 clinical trial. JAMA Dermatology, 152(7):837-839.

Altmetrics

Downloads

0 downloads since deposited on 14 Apr 2016
0 downloads since 12 months

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:23 March 2016
Deposited On:14 Apr 2016 17:56
Last Modified:15 Jul 2016 01:02
Publisher:American Medical Association (AMA)
ISSN:2168-6068
Publisher DOI:https://doi.org/10.1001/jamadermatol.2016.0401
PubMed ID:27007550

Download

[img]
Content: Published Version
Language: English
Filetype: PDF - Registered users only
Size: 65kB
View at publisher

Author Collaborations